Investigator Site 0010104 — Weston, Florida

Investigator Site 0010104 is a clinical research site located in Weston, Florida, United States 33331.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 0010104 has participated in 1 clinical trials.

Therapeutic areas: Primary Immune Thrombocytopenia.

Sponsors: argenx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Weston

Browse all research sites in Florida · View every site in Weston

• Cleveland Clinic Weston Hospital
• Weston Hospital
• Cleveland Clinic Florida, Weston Hospital
• University of South Florida-Cleveland Clinic Florida
• Cleveland Clinic Florida Hospital
• Cleveland Clinic Foundation - Florida Weston Hospital
• Weston Hospital/Cleveland Clinic Florida
• Cleveland Clinic
• Cleveland Clinic-Weston
• Encore Medical Research of Weston
• Cleveland Clinic Florida Weston
• Encore Medical Research-Weston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 0010104?

Investigator Site 0010104 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 0010104 conducted?

Investigator Site 0010104 has 1 clinical trials on record. Their work covers Primary Immune Thrombocytopenia.

Is Investigator Site 0010104 accredited by Crixeo Clinical Trials?

Investigator Site 0010104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 0010104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.